Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oppenheimer Reiterates Outperform on Veru, Lowers Price Target to $5

Author: Benzinga Newsdesk | April 15, 2024 07:55am
Oppenheimer analyst Leland Gershell reiterates Veru (NASDAQ:VERU) with a Outperform and lowers the price target from $7 to $5.

Posted In: VERU

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist